Comparison of Online Prescription Services Between Good Doctor and Halodoc at Nizam Farma Pharmacy
DOI:
https://doi.org/10.58511/v3i1.10215Keywords:
Drug access, Good Doctor, Halodoc, online prescription, pharmacyAbstract
Pharmaceutical services play a pivotal role in healthcare delivery and have increasingly evolved through the integration of digital technologies, particularly online prescription services. This study compared the characteristics of online prescription services provided through Good Doctor and Halodoc at Nizam Farma Pharmacy between January and March 2025. A quantitative descriptive study was conducted using archived electronic prescription records obtained from both platforms. The data were analyzed based on prescription volume, physician specialty, medication categories, and medication access outcomes. The results indicated that Halodoc generated the highest proportion of prescriptions (61.6%), predominantly issued by general practitioners (76.5%), with symptomatic medications and antibiotics representing the most frequently prescribed drug categories. Conversely, prescriptions received through Good Doctor were primarily issued by specialist physicians (73.6%) and were largely intended for the management of mild conditions, including allergic disorders and upper respiratory tract illnesses. Overall, the findings indicate that online prescription platforms have the potential to improve medication access and support pharmaceutical services in community pharmacy practice.
References
[1] World Health Organization, Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: WHO Press, 2003.
[2] E. Li, J. Clarke, H. Ashrafian, A. Darzi, and A. L. Neves, "The impact of electronic health record interoperability on safety and quality of care in high-income countries: A systematic review," J. Med. Internet Res., vol. 24, no. 9, Art. no. e38144, Sep. 2022.
[3] V. C. Ezeamii, O. E. Okobi, H. Wambai-Sani, G. S. Perera, S. Zaynieva, C. C. Okonkwo, M. M. Ohaiba, P. C. William-Enemali, O. R. Obodo, and N. G. Obiefuna, "Revolutionizing healthcare: How telemedicine is improving patient outcomes and expanding access to care," Cureus, vol. 16, no. 7, Jul. 2024.
[4] Ministry of Health Republic of Indonesia, Regulation of the Minister of Health of the Republic of Indonesia No. 20 of 2019 on the Organization of Telemedicine Among Healthcare Facilities. Jakarta, Indonesia: Ministry of Health, 2019.
[5] S. N. Gajarawala and J. N. Pelkowski, "Telehealth benefits and barriers," J. Nurse Pract., vol. 17, no. 2, pp. 218–221, Feb. 2021.
[6] O. Eriksson and S. E. Öhlund, "Digital institutionalization: The case of e-prescribing," J. Assoc. Inf. Syst., vol. 25, no. 3, pp. 569–593, 2024.
[7] M. Nguyen, M. Waller, A. Pandya, and J. Portnoy, "A review of patient and provider satisfaction with telemedicine," Curr. Allergy Asthma Rep., vol. 20, no. 11, Art. no. 72, Nov. 2020.
[8] M. A. Alabdali and K. S. Husain, "Understanding the relationship between patient satisfaction and loyalty through telemedicine platform quality: An empirical study," Int. J. Health Care Manag., vol. 18, no. 2, pp. 253–265, Apr. 2025.
[9] D. Aluga, L. A. Nnyanzi, N. King, E. A. Okolie, and P. Raby, "Effect of electronic prescribing compared to paper-based (handwritten) prescribing on primary medication adherence in an outpatient setting: A systematic review," Appl. Clin. Inform., vol. 12, no. 4, pp. 845–855, Aug. 2021.
[10] J. W. Creswell, Research Design: Qualitative, Quantitative, and Mixed Methods Approaches, 4th ed. Thousand Oaks, CA, USA: SAGE Publications, 2014.
[11] Y. Xu, X. Zheng, Y. Li, X. Ye, H. Cheng, H. Wang, and J. Lyu, "Exploring patient medication adherence and data mining methods in clinical big data: A contemporary review," J. Evid.-Based Med., vol. 16, no. 3, pp. 342–375, Sep. 2023.
[12] S. K. Grove, N. Burns, and J. R. Gray, The Practice of Nursing Research: Appraisal, Synthesis, and Generation of Evidence, 7th ed. St. Louis, MO, USA: Elsevier Saunders, 2013.
[13] O. P. Dahlan, "Digital health in Indonesia: A literature review of adoption, infrastructure, equity, and health-system transformation," Health Econ. Insights J., vol. 1, no. 1, pp. 20–38, Jun. 2026.
[14] Halodoc Pte. Ltd., Halodoc Annual Platform Report 2022–2023. Jakarta, Indonesia: Halodoc, 2023.
[15] Halodoc Pte. Ltd., "About Halodoc: Company Overview," 2023. [Online]. Available: https://www.halodoc.com. [Accessed: Mar. 31, 2025].
[16] R. A. Lee, J. T. Stripling, B. Spellberg, and R. M. Centor, "Short-course antibiotics for common infections: What do we know and where do we go from here?," Clin. Microbiol. Infect., vol. 29, no. 2, pp. 150–159, Feb. 2023.
[17] World Health Organization, Global Action Plan on Antimicrobial Resistance. Geneva, Switzerland: WHO Press, 2015.
[18] S. Pathak, C. M. Blanchard, E. Moreton, and B. Y. Urick, "A systematic review of the effect of telepharmacy services in the community pharmacy setting on care quality and patient safety," J. Health Care Poor Underserved, vol. 32, no. 2, pp. 737–750, 2021.
[19] D. Acosta, "Impact of telepharmacy on patients' medication adherence and drug-related problem incidents: A systematic review," Int. Pharm. Acta, vol. 8, no. 1, Art. no. e8-1, May 2025.
[20] Good Doctor Technology Indonesia, "Corporate Partnership Program Overview," 2023. [Online]. Available: https://www.gooddoctor.co.id. [Accessed: Mar. 31, 2025].
[21] R. Wootton, N. G. Patil, R. E. Scott, and K. Ho, Telehealth in the Developing World. London, U.K.: Royal Society of Medicine Press, 2009.
